High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$133K
$133,971
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
FDMT
S
4D Molecular Therapeutics, Inc.
Gupta Ashoo
• Officer • VP, Finance and Controller
Sell to Cover
2026-03-20
$3,358x2
|
||||||
| FDMT |
4D Molecular Therapeutics, Inc.
|
Officer • VP, Finance and Controller
Sell to Cover
|
2026-03-20 | $3,358x2 | S | Form 4 |
|
FDMT
M
4D Molecular Therapeutics, Inc.
Gupta Ashoo
• Officer • VP, Finance and Controller
Equity Compensation
2025-12-20
$0x2
|
||||||
| FDMT |
4D Molecular Therapeutics, Inc.
|
Officer • VP, Finance and Controller
Equity Compensation
|
2025-12-20 | $0x2 | M | Form 4 |
|
FDMT
S
4D Molecular Therapeutics, Inc.
Gupta Ashoo
• Officer • VP, Finance and Controller
Sell to Cover
2025-12-20
$3,377x2
|
||||||
| FDMT |
4D Molecular Therapeutics, Inc.
|
Officer • VP, Finance and Controller
Sell to Cover
|
2025-12-20 | $3,377x2 | S | Form 4 |
|
FDMT
M
4D Molecular Therapeutics, Inc.
Bizily Scott
• Officer • Chief Legal Officer
Equity Compensation
2025-12-16
$6,769x2
|
||||||
| FDMT |
4D Molecular Therapeutics, Inc.
|
Officer • Chief Legal Officer
Equity Compensation
|
2025-12-16 | $6,769x2 | M | Form 4 |
|
FDMT
S
4D Molecular Therapeutics, Inc.
Bizily Scott
• Officer • Chief Legal Officer
10b5-1 SellΔOwn -31.3%
2025-12-16
$17,822
|
||||||
| FDMT |
4D Molecular Therapeutics, Inc.
|
Officer • Chief Legal Officer
10b5-1 SellΔOwn -31.3%
|
2025-12-16 | $17,822 | S | Form 4 |
|
FDMT
M
4D Molecular Therapeutics, Inc.
THEUER CHARLES
• Director
Equity Compensation
2025-12-12
$10,640x2
|
||||||
| FDMT |
4D Molecular Therapeutics, Inc.
|
Director
Equity Compensation
|
2025-12-12 | $10,640x2 | M | Form 4 |
|
FDMT
M
4D Molecular Therapeutics, Inc.
Bizily Scott
• Officer • Chief Legal Officer
Other
2025-11-17
$6,769
|
||||||
| FDMT |
4D Molecular Therapeutics, Inc.
|
Officer • Chief Legal Officer
Other
|
2025-11-17 | $6,769 | M | Form 4 |
|
FDMT
S
4D Molecular Therapeutics, Inc.
Bizily Scott
• Officer • Chief Legal Officer
10b5-1 SellΔOwn -31.3%
2025-11-17
$17,315
|
||||||
| FDMT |
4D Molecular Therapeutics, Inc.
|
Officer • Chief Legal Officer
10b5-1 SellΔOwn -31.3%
|
2025-11-17 | $17,315 | S | Form 4 |
|
FDMT
M
4D Molecular Therapeutics, Inc.
Bizily Scott
• Officer • Chief Legal Officer
Other
2025-10-24
$7,035
|
||||||
| FDMT |
4D Molecular Therapeutics, Inc.
|
Officer • Chief Legal Officer
Other
|
2025-10-24 | $7,035 | M | Form 4 |
|
FDMT
S
4D Molecular Therapeutics, Inc.
Bizily Scott
• Officer • Chief Legal Officer
10b5-1 SellΔOwn -42.7%
2025-10-24
$32,136
|
||||||
| FDMT |
4D Molecular Therapeutics, Inc.
|
Officer • Chief Legal Officer
10b5-1 SellΔOwn -42.7%
|
2025-10-24 | $32,136 | S | Form 4 |
|
FDMT
M
4D Molecular Therapeutics, Inc.
Bizily Scott
• Officer • Chief Legal Officer
Other
2025-10-16
$6,769
|
||||||
| FDMT |
4D Molecular Therapeutics, Inc.
|
Officer • Chief Legal Officer
Other
|
2025-10-16 | $6,769 | M | Form 4 |
|
FDMT
S
4D Molecular Therapeutics, Inc.
Bizily Scott
• Officer • Chief Legal Officer
10b5-1 SellΔOwn -24.0%
2025-10-16
$16,628
|
||||||
| FDMT |
4D Molecular Therapeutics, Inc.
|
Officer • Chief Legal Officer
10b5-1 SellΔOwn -24.0%
|
2025-10-16 | $16,628 | S | Form 4 |
|
FDMT
S
4D Molecular Therapeutics, Inc.
Bizily Scott
• Officer • Chief Legal Officer
10b5-1 SellΔOwn -31.7%
2025-10-09
$24,080
|
||||||
| FDMT |
4D Molecular Therapeutics, Inc.
|
Officer • Chief Legal Officer
10b5-1 SellΔOwn -31.7%
|
2025-10-09 | $24,080 | S | Form 4 |
|
FDMT
S
4D Molecular Therapeutics, Inc.
Bizily Scott
• Officer • Chief Legal Officer
10b5-1 SellΔOwn -24.1%
2025-09-23
$19,256
|
||||||
| FDMT |
4D Molecular Therapeutics, Inc.
|
Officer • Chief Legal Officer
10b5-1 SellΔOwn -24.1%
|
2025-09-23 | $19,256 | S | Form 4 |